IL1B and COVID-19: The remainder of fecal cytokines analyzed (IL-1β, IL-1ra, IL-6, IL-8, IL-17, TNFα) were not significantly different in COVID-19 patients compared to controls nor associated with severity of disease (Fig. 3A,B). We found no difference in the concentration of any fecal cytokine between those patients reporting diarrhea compared to those without diarrhea (Fig. S3A).